We reported that down-regulation of CHIT1, SIGLEC15, PLA2G2D and TMEM163 was associated with poor prognosis in immunocompetent NHL, and expression levels of four genes were lower in lymphoma than in normal tissues. This evidence concerns the gene CHIT1 and non-Hodgkin lymphoma.